BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 27083761)

  • 1. In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study.
    Leruez-Ville M; Ghout I; Bussières L; Stirnemann J; Magny JF; Couderc S; Salomon LJ; Guilleminot T; Aegerter P; Benoist G; Winer N; Picone O; Jacquemard F; Ville Y
    Am J Obstet Gynecol; 2016 Oct; 215(4):462.e1-462.e10. PubMed ID: 27083761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection.
    Jacquemard F; Yamamoto M; Costa JM; Romand S; Jaqz-Aigrain E; Dejean A; Daffos F; Ville Y
    BJOG; 2007 Sep; 114(9):1113-21. PubMed ID: 17617198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of predicting the outcome of fetal infection with cytomegalovirus at the time of prenatal diagnosis.
    Leruez-Ville M; Stirnemann J; Sellier Y; Guilleminot T; Dejean A; Magny JF; Couderc S; Jacquemard F; Ville Y
    Am J Obstet Gynecol; 2016 Sep; 215(3):342.e1-9. PubMed ID: 27063062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus infection during pregnancy: state of the science.
    Leruez-Ville M; Foulon I; Pass R; Ville Y
    Am J Obstet Gynecol; 2020 Sep; 223(3):330-349. PubMed ID: 32105678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal valacyclovir and infant cytomegalovirus acquisition: a randomized controlled trial among HIV-infected women.
    Roxby AC; Atkinson C; Asbjörnsdóttir K; Farquhar C; Kiarie JN; Drake AL; Wald A; Boeckh M; Richardson B; Emery V; John-Stewart G; Slyker JA
    PLoS One; 2014; 9(2):e87855. PubMed ID: 24504006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital cytomegalovirus infection: management update.
    Khalil A; Jones C; Ville Y
    Curr Opin Infect Dis; 2017 Jun; 30(3):274-280. PubMed ID: 28338486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and safety of prenatal valacyclovir for congenital cytomegalovirus infection: systematic review and meta-analysis.
    D'Antonio F; Marinceu D; Prasad S; Khalil A
    Ultrasound Obstet Gynecol; 2023 Apr; 61(4):436-444. PubMed ID: 36484439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of perinatal herpes: prophylactic antiviral therapy?
    Scott LL
    Clin Obstet Gynecol; 1999 Mar; 42(1):134-48; quiz 174-5. PubMed ID: 10073307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary maternal cytomegalovirus infections: accuracy of fetal ultrasound for predicting sequelae in offspring.
    Leyder M; Vorsselmans A; Done E; Van Berkel K; Faron G; Foulon I; Naessens A; Jansen A; Foulon W; Gucciardo L
    Am J Obstet Gynecol; 2016 Nov; 215(5):638.e1-638.e8. PubMed ID: 27287685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin: a multicenter study in Madrid.
    Blázquez-Gamero D; Galindo Izquierdo A; Del Rosal T; Baquero-Artigao F; Izquierdo Méndez N; Soriano-Ramos M; Rojo Conejo P; González-Tomé MI; García-Burguillo A; Pérez Pérez N; Sánchez V; Ramos-Amador JT; De la Calle M
    J Matern Fetal Neonatal Med; 2019 Feb; 32(4):617-625. PubMed ID: 28978246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valacyclovir in primary maternal CMV infection for prevention of vertical transmission: A case-series.
    De Santis M; Apicella M; De Luca C; D'Oria L; Valentini P; Sanguinetti M; Lanzone A; Scambia G; Santangelo R; Masini L
    J Clin Virol; 2020 Jun; 127():104351. PubMed ID: 32325395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal high-dose valacyclovir and its correlation with newborn blood viral load and outcome in congenital cytomegalovirus infection.
    Goncé A; Hawkins-Villarreal A; Salazar L; Guirado L; Marcos MA; Pascual Mancho J; Prats P; López M; Eixarch E; Salvia MD; Fortuny C; Figueras F
    J Matern Fetal Neonatal Med; 2022 Oct; 35(20):4004-4008. PubMed ID: 33143511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal cytomegalovirus infection.
    Leruez-Ville M; Ville Y
    Best Pract Res Clin Obstet Gynaecol; 2017 Jan; 38():97-107. PubMed ID: 27923540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valacyclovir therapy to reduce recurrent genital herpes in pregnant women.
    Andrews WW; Kimberlin DF; Whitley R; Cliver S; Ramsey PS; Deeter R
    Am J Obstet Gynecol; 2006 Mar; 194(3):774-81. PubMed ID: 16522412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valacyclovir prevention of cytomegalovirus reactivation after heart transplantation: a randomized trial.
    Egan JJ; Carroll KB; Yonan N; Woodcock A; Crisp A
    J Heart Lung Transplant; 2002 Apr; 21(4):460-6. PubMed ID: 11927223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of cytomegalovirus infection in pregnancy: is it time for valacyclovir?
    Zammarchi L; Lazzarotto T; Andreoni M; Campolmi I; Pasquini L; Di Tommaso M; Simonazzi G; Tomasoni LR; Castelli F; Galli L; Borchi B; Clerici P; Bartoloni A; Tavio M; Trotta M
    Clin Microbiol Infect; 2020 Sep; 26(9):1151-1154. PubMed ID: 32289479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report on early treatment with valaciclovir after maternal primary cytomegalovirus infection.
    Codaccioni C; Vauloup-Fellous C; Letamendia E; Saada J; Benachi A; Vivanti AJ
    J Gynecol Obstet Hum Reprod; 2019 Apr; 48(4):287-289. PubMed ID: 30634004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drugs against human cytomegalovirus].
    Leśnikowski ZJ; Paradowska E; Przepiórkiewicz M; Olejniczak A; Emery VC
    Pol Merkur Lekarski; 2002 Sep; 13(75):242-9. PubMed ID: 12474580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome.
    Enders G; Bäder U; Lindemann L; Schalasta G; Daiminger A
    Prenat Diagn; 2001 May; 21(5):362-77. PubMed ID: 11360277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants.
    Ljungman P; de La Camara R; Milpied N; Volin L; Russell CA; Crisp A; Webster A;
    Blood; 2002 Apr; 99(8):3050-6. PubMed ID: 11929799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.